GGrantIndex
← Leaderboards

Lucigen Corporation

Middleton, WI

Compare ↔
$25,840,621
Total funding
49
Grants

Funding over time

peak $3.5M · FY200517
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17

Funding mix

By agency

NIH$23,263,809 · 43
NSF$1,344,812 · 4
DOE$1,232,000 · 2

By mechanism

R44$13,906,000 · 11
R43$6,466,958 · 29
$2,576,812 · 6
R33$1,748,170 · 1
R41$702,147 · 1
R21$440,534 · 1

Investigators at Lucigen Corporation

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Largest grants

NEW AWARD TO LUCIGEN CORPORATION FOR ITS PROJECT ENTITLED, "NOVEL ENZYME PRODUCTS FOR THE CONVERSION OF DEFATTED SOYBEAN MEAL TO ETHANOL."$1,232,000
· FY2008 · Department of Energy
SBIR Phase II: Molecular Diagnostics and Biological Control of Disease in Farmed Channel Catfish$1,045,760
· FY2011 · TIP
Random Shear Shuttle BAC Libraries for Antimicrobial Discovery from Soil Metageno$1,000,000
R44 · FY2013 · AI
Random Shear Shuttle BAC Libraries for Antimicrobial Discovery from Soil Metageno$1,000,000
R44 · FY2012 · AI
Point of Care Detection of Respiratory Viruses$995,154
R44 · FY2012 · AI
Point of Care Detection of Respiratory Viruses$860,797
R44 · FY2013 · AI
Point of Care Detection of Respiratory Viruses$830,014
R44 · FY2014 · AI
Mini Chromosome and Fluorescent Proteins for Expression of Protein Complexes$766,950
R44 · FY2016 · GM
Mini Chromosome and Fluorescent Proteins for Expression of Protein Complexes$732,692
R44 · FY2015 · GM
NOVEL SOLUBILITY-ENHANCING PROTEIN EXPRESSION TECHNOLOGY$649,620
R44 · FY2013 · GM
Novel systems for mammalian expression, integration, and knockout of previously "$600,001
R44 · FY2010 · GM
Novel systems for mammalian expression, integration, and knockout of previously "$599,999
R44 · FY2011 · GM
Random Shear Shuttle BAC Libraries for Antimicrobial Discovery from Soil Metageno$551,410
R44 · FY2014 · AI
Structure-Stabilized GPCRs for Functional Analysis and Crystallography$542,558
R44 · FY2011 · MH
Structure-Stabilized GPCRs for Functional Analysis and Crystallography$483,295
R44 · FY2012 · MH
Rapid Field Appropriate Diagnostics for Select Biodefense and Emerging Pathogens$450,870
R33 · FY2015 · AI
Rapid Field Appropriate Diagnostics for Select Biodefense and Emerging Pathogens$445,587
R33 · FY2016 · AI
Improved DNA Polymerases for Genomic Sequencing$443,433
R44 · FY2007 · HG
Structure-Stabilized GPCRs for Functional Analysis and Crystallography$435,307
R44 · FY2010 · MH
Rapid Field Appropriate Diagnostics for Select Biodefense and Emerging Pathogens$427,970
R33 · FY2014 · AI